Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 5 346,56 ₴, with a 24-hour trading volume of 47,25B ₴. The asset's market cap is 13,2T ₴, after moving 0.44% in the last day.
Tokenized Merck & Co Inc is trading at 5 381,8 ₴, with a tokenized market cap of 1,76B ₴ and a 24-hour trading volume of 42,71M ₴. The tokenized asset has moved 0.01% in the past 24 hours.